Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Ultrasound Med ; 42(9): 2095-2105, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37163223

RESUMEN

OBJECTIVES: Since 2016, the French CNEOF included the left ventricular outflow tract (LVOT) in the second and third trimester of pregnancy in addition to the four-chamber view and the parasagittal view of the right outflow tract. The objective of this study was to define quality criteria for fetal LVOT assessment and to perform a human audit of past and current practices, before and after the implementation of those quality criteria at a large scale. METHODS: Seven quality criteria were investigated and rated from 0 to 1 during three periods of interest. Files were randomly selected from three centers, and average total and specific scores were calculated. RESULTS: LVOT pictures were present in more than 94.3% of reports. The average quality score was 5.49/7 (95% confidence interval [CI]: 5.36-5.62), 5.91/7 (95% CI: 5.80-6.03), and 5.70/7 (95% CI: 5.58-5.82) for the three centers in the three periods of interest. There was no significant difference following the introduction of the quality criteria, 2017 versus 2020, P = .054. CONCLUSION: Fetal LVOT images were present in most of ultrasound reports but the introduction of the proposed quality criteria under human supervision seems not associated with a significant change in practice.


Asunto(s)
Cardiopatías Congénitas , Embarazo , Femenino , Humanos , Cardiopatías Congénitas/diagnóstico por imagen , Ultrasonografía Prenatal/métodos , Corazón Fetal/diagnóstico por imagen , Diagnóstico Prenatal
2.
Fertil Steril ; 104(5): 1319-24, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26149354

RESUMEN

OBJECTIVE: To determine the long-term outcomes of patients with an isolated ovarian recurrence after fertility sparing surgery (FSS) for epithelial ovarian cancer (EOC) and to evaluate the recurrence rates (and location) according to the new 2014 International Federation of Gynecology and Obstetrics (FIGO) staging system. DESIGN: Retrospective multicenter study. SETTING: Teams having reported recurrence after FSS for EOC. PATIENT(S): Four series comprising 545 patients undergoing FSS and 63 (12%) recurrences. INTERVENTION(S): FSS (salpingo-oophorectomy for a majority of cases) for EOC. MAIN OUTCOMES MEASURE(S): Recurrences rates and characteristics of recurrent disease. RESULT(S): Among 63 recurrent patients, 24 (38%) recurrences were isolated on the spared ovary, and 39 (62%) arose at an extraovarian site. Among the patients with an isolated ovarian recurrence, three patients died after a median follow-up period of 186 months (range: 28-294 months). Among the patients with recurrent extraovarian disease, 24 died and 7 were alive with persistent disease after a median follow-up period of 34 months (range: 3-231 months). The overall rate of isolated ovarian and extrapelvic recurrences was higher for grade 3 tumors (compared with grades 1/2). CONCLUSION(S): The long-term survival of patients with an isolated ovarian recurrence after FSS for EOC remains favorable. The prognosis of patients with an extraovarian recurrence is poor compared with those who have an isolated recurrent ovarian tumor. Grade 3 tumors (compared to grades 1/2) give rise to a higher rate of extraovarian recurrences.


Asunto(s)
Preservación de la Fertilidad/métodos , Recurrencia Local de Neoplasia , Neoplasias Glandulares y Epiteliales/cirugía , Neoplasias Ováricas/cirugía , Ovariectomía , Salpingectomía , Adolescente , Adulto , Carcinoma Epitelial de Ovario , Europa (Continente) , Femenino , Preservación de la Fertilidad/efectos adversos , Preservación de la Fertilidad/mortalidad , Humanos , Japón , Estadificación de Neoplasias , Neoplasias Glandulares y Epiteliales/mortalidad , Neoplasias Glandulares y Epiteliales/secundario , Neoplasias Ováricas/mortalidad , Neoplasias Ováricas/patología , Ovariectomía/efectos adversos , Ovariectomía/mortalidad , Estudios Retrospectivos , Factores de Riesgo , Salpingectomía/efectos adversos , Salpingectomía/mortalidad , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
3.
J Exp Biol ; 210(Pt 17): 3015-26, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17704076

RESUMEN

The in vitro brainstem preparation from Rana catesbeiana shows a functional central O(2) chemoreflex. Acute brainstem exposure to hypoxic superfusate elicits lung burst frequency responses that change over the course of development. Based on studies suggesting that brainstem noradrenergic neurons are involved in this reflex, we tested the following two hypotheses in vitro: (1) activation of adrenoceptors is necessary for the expression of the fictive lung ventilation response to hypoxia, and (2) changes in fast, Cl(-)-dependent neurotransmission (GABA/glycine) contribute to developmental changes in noradrenergic modulation. Experiments were performed on preparations from pre-metamorphics tadpoles (TK stages V-XIII) and adult bullfrogs. Acute exposure to hypoxic superfusate (98% N(2), 2% CO(2)) increased fictive lung ventilation frequency in the pre-metamorphic group, whereas a decrease was observed in adults. Buccal burst frequency was unchanged by hypoxia. Noradrenaline (NA; 5 micromol l(-1)) bath application mimicked both fictive breathing responses and application of the alpha(1)-antagonist prazosine (0.5 micromol l(-1)) blocked the lung burst response to hypoxia in both groups. Blocking GABA(A)/glycine receptors with a bicuculine/strychnine mixture (1.25 micromol l(-1)/1.5 micromol l(-1), respectively) or activation of GABA(B) pre-synaptic autoreceptors with baclofen (0.5 micromol l(-1)) prevented the lung burst response to hypoxia and to the alpha(1)-agonist phenylephrine (25 micromol l(-1)) in both stage groups. We conclude that NA modulation contributes to the central O(2) chemoreflex in bullfrog, which acts via GABA/glycine pathways. These data suggest that maturation of GABA/glycine neurotransmission contributes to the developmental changes in this chemoreflex.


Asunto(s)
Oxígeno/metabolismo , Rana catesbeiana/metabolismo , Agonistas alfa-Adrenérgicos/farmacología , Animales , Baclofeno/farmacología , Agonistas del GABA/farmacología , Técnicas In Vitro , Pulmón/efectos de los fármacos , Pulmón/fisiología , Metamorfosis Biológica , Norepinefrina/farmacología , Rana catesbeiana/crecimiento & desarrollo , Receptores Adrenérgicos/efectos de los fármacos , Receptores Adrenérgicos/fisiología , Receptores de GABA/efectos de los fármacos , Receptores de GABA/fisiología , Receptores de Glicina/efectos de los fármacos , Receptores de Glicina/fisiología , Respiración/efectos de los fármacos , Transmisión Sináptica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...